Bayesian network meta-analysis of nine FDA-approved VEGFR-TKIs demonstrated their impact on the occurrence of all grades and grade 3 or higher cardiovascular events, hypertension and cardiac damage [11]. The gene discussed is KDR; the disease is Hypertension.